(MENAFN- EIN Presswire)
Digestive Remedies market size, share, demad, growth
PORTLAND, OR, UNITED STATES, October 22, 2024 /EINPresswire / -- The global digestive and intestinal remedies market , valued at $18,250.0 million in 2021, is projected to grow to $26,243.4 million by 2031, with a CAGR of 3.6%. This growth is driven by increasing gastrointestinal (GI) disorders such as heartburn, bloating, indigestion, constipation, and diarrhea.
Key Market Drivers
.Rising GI Disorders: Prevalence of conditions like acid reflux, irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD).
.Increased OTC Product Demand: Growing consumer demand for over-the-counter (OTC) treatments like antacids, stool softeners, and proton pump inhibitors.
.Changing Dietary Habits: Modern eating patterns contributing to digestive problems.
Market Challenges
.Alternative Therapies: Availability of alternative treatments may slow market growth.
.Supplementary Food Consumption: Rise in digestive supplements could reduce reliance on traditional remedies.
Market Opportunities
.Emerging Markets: Economic growth and healthcare investments in Asia-Pacific and Latin America provide opportunities for expansion.
.Product Innovation: New product launches and increasing healthcare expenditure are enhancing market growth prospects.
Get a Sample Copy of this Report:
Market Segmentation
1. By Type
.Digestive Medicines: Includes products like antacids and stool softeners.
.Projected CAGR: 4.6% (2022-2031).
.Gastrointestinal Agents and Remedies: Expected to dominate the market due to increased usage of agents such as protectives and adsorbents.
2. By Age Group
.Pediatric: Focused on children's digestive health.
.Adult: Dominates the market, driven by the rising prevalence of digestive issues in older populations.
.CAGR: 3.7% (2022-2031).
3. By Distribution Channel
.Offline: Physical pharmacies hold a significant market share.
.Online: Growing at a faster rate (CAGR of 4.4%) due to increasing e-commerce adoption for purchasing remedies.
Regional Insights
.Europe: Largest market share in 2021, attributed to well-developed healthcare systems, research advancements, and a strong presence of key players.
.Asia-Pacific: Expected to grow at the fastest CAGR (4.6%) due to rising awareness of gastrointestinal disorders and increasing healthcare expenditure.
Key Market Players
.Abbott Laboratories
.Bayer AG
.GlaxoSmithKline Plc
.Johnson & Johnson
.Pfizer Inc.
.Sanofi S.A.
These companies are actively involved in research and development, product launches, and market expansion strategies to cater to the growing demand for digestive remedies.
The global digestive and intestinal remedies market is set to witness steady growth, driven by rising gastrointestinal disorders and growing demand for both OTC and prescription treatments. Opportunities lie in emerging markets and product innovations, while challenges include the rise of alternative therapies.
Enquire Before Buying:
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN22102024003118003196ID1108805269
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.